Recovery ⏱ Half-life: Short.

Bronchogen

Bronchogen (AED Peptide)

Buy from $29.99 →
Half-Life
Short.
Mol. Weight
~320 g/mol

What is Bronchogen?

Bronchogen is a synthetic tripeptide bioregulator designed to support bronchial and respiratory tissue function.

Research Applications

Respiratory tissue support, bronchial inflammation, and epithelial recovery research.

Dosage Information (Research Use)

10-20 mg/day for 10-30 day courses. Research use only.

Reconstitution & Handling

Standard BAC water or oral capsules.

Half-Life & Pharmacokinetics

Short.

Reported Observations in Literature

Generally well-tolerated.

Key Research References

  • Khavinson VK. “Peptide Bioregulators.” Neuro Endocrinol Lett. 2003

How Bronchogen Works

Bronchogen targets bronchial mucosa, modulating gene expression in epithelial cells to support respiratory tissue integrity and inflammatory balance.

Research Findings

Part of the Khavinson peptide bioregulator series. Studied in chronic obstructive respiratory conditions.

Dosage & Administration

10-20 mg/day for 10-30 day courses. Research use only.

Safety & Side Effects

Generally well-tolerated.

Important: All safety information is derived from published research, primarily animal studies. No controlled human clinical trial data exists unless explicitly noted. This compound is sold for research purposes only.

Quick Facts

Sequence Ala-Glu-Asp
Molecular Weight ~320 g/mol
Half-Life Short.
Available Sizes 5mg
Storage Lyophilized: -20°C.

Key Research References

  • Khavinson VK. "Peptide Bioregulators." Neuro Endocrinol Lett. 2003

Get Bronchogen from SourcePeptides

Third-party tested • Research-grade purity • Fast US shipping

Shop Now →

Related Peptides

View all →
Recovery
FDA-approved modified C-type natriuretic peptide analog that promotes bone growth in children with achondroplasia.
Recovery
Tripeptide bioregulator studied for lung and bronchial tissue support and mucosal recovery.
Recovery
Thymus-derived peptide complex researched for immune system restoration and T-cell function normalization in aging and immunodeficiency.